Maritn Rosenzweig, MD
Articles
Defining and Recognizing Treatment-Resistant Depression (TRD)
Steven Levine, MD;Patricia Ares-Romero, MD, FASAM;Carrie Jardine;Samuel Norberg, PhD;Maritn Rosenzweig, MD
September 27th 2024Samuel Nordberg, PhD, discusses challenges with the definition and identification of TRD in the clinical setting.
Read More
Effective Care Delivery for TRD
Steven Levine, MD;Patricia Ares-Romero, MD, FASAM;Carrie Jardine;Samuel Norberg, PhD;Maritn Rosenzweig, MD
September 27th 2024Drs Samuel Nordberg, Patricia Ares-Romero, and Martin Rosenzweig share considerations for effective care delivery for patients with TRD.
Read More
Approaching Patient Identification for Alternative Therapies for TRD
Steven Levine, MD;Patricia Ares-Romero, MD, FASAM;Carrie Jardine;Samuel Norberg, PhD;Maritn Rosenzweig, MD
September 27th 2024Dr. Samuel Nordberg discusses methods for identifying patients in need of an alternative therapy for TRD at the health system level.
Read More
Latest Updated Articles
Published: October 3rd 2024 | Updated: October 6th 2024
Breast Cancer Mortality Drops 44%, ACS Reports
Published: October 3rd 2024 | Updated: October 6th 2024
Obese Patients Have ‘Significantly Higher’ Severe Atopic Dermatitis, Abnormal Lipid Profiles, Study Finds
Published: September 17th 2024 | Updated: October 6th 2024
Boehringer Ingelheim's IPF Drug Meets Primary End Point
Published: September 27th 2024 | Updated: October 6th 2024
FDA Approves the Oral Medication KarXT for Schizophrenia
Published: September 20th 2024 | Updated: October 6th 2024
Insights into Emerging Technologies in Pain Medicine
Published: September 27th 2024 | Updated: October 6th 2024
FDA Approves Dupixent for Patients with COPD
